[Steroid and nonsteroid postcoital contraceptives]

Area of Science:

• Reproductive biology
• Pharmacology
• Endocrinology

Background:

• The preimplantation period is critical for early embryonic development.
• Hormonal regulation, including luteinizing hormone (LH), plays a key role in pregnancy establishment.
• Combined drug therapies are explored for enhanced contraceptive efficacy.

Purpose of the Study:

• To investigate the contraceptive efficacy of a combined therapy.
• To elucidate the mechanism of action for this combined contraceptive approach.
• To assess the impact on hormonal regulation and early fetal development.

Main Methods:

• Experimental administration of combined estrogen-norsteroids, prostaglandins, and neurotropic substances.
• Analysis of hormonal levels, specifically luteinizing hormone (LH) secretion.
• Evaluation of the effects on the amount and condition of developing fetuses during the preimplantation period.

Main Results:

• The combined use of estrogen-norsteroids, prostaglandins, and neurotropic substances demonstrated a potent contraceptive effect.
• The mechanism involves the inhibition of luteinizing hormone (LH) incretion.
• Variations in the amount and condition of developing fetuses were observed, linked to LH inhibition.

Conclusions:

• Combined therapy with specific steroids, prostaglandins, and neurotropic drugs is highly effective for contraception.
• The primary mechanism of action is the suppression of LH secretion.
• This hormonal modulation significantly influences early pregnancy outcomes.